APM
Price
$0.96
Change
+$0.04 (+4.35%)
Updated
Jul 3 closing price
Capitalization
6.86M
PGEN
Price
$1.62
Change
+$0.01 (+0.62%)
Updated
Jul 3 closing price
Capitalization
478.19M
37 days until earnings call
Interact to see
Advertisement

APM vs PGEN

Header iconAPM vs PGEN Comparison
Open Charts APM vs PGENBanner chart's image
Aptorum Group
Price$0.96
Change+$0.04 (+4.35%)
Volume$15.26K
Capitalization6.86M
Precigen
Price$1.62
Change+$0.01 (+0.62%)
Volume$611.4K
Capitalization478.19M
APM vs PGEN Comparison Chart in %
Loading...
APM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APM vs. PGEN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APM is a Hold and PGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (APM: $0.96 vs. PGEN: $1.62)
Brand notoriety: APM and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APM: 28% vs. PGEN: 35%
Market capitalization -- APM: $6.86M vs. PGEN: $478.19M
APM [@Biotechnology] is valued at $6.86M. PGEN’s [@Biotechnology] market capitalization is $478.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APM’s FA Score shows that 2 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • APM’s FA Score: 2 green, 3 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, APM is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APM’s TA Score shows that 3 TA indicator(s) are bullish while PGEN’s TA Score has 7 bullish TA indicator(s).

  • APM’s TA Score: 3 bullish, 7 bearish.
  • PGEN’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than APM.

Price Growth

APM (@Biotechnology) experienced а -3.03% price change this week, while PGEN (@Biotechnology) price change was +13.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

APM is expected to report earnings on Apr 30, 2025.

PGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($478M) has a higher market cap than APM($6.86M). PGEN YTD gains are higher at: 44.643 vs. APM (-65.714). APM has higher annual earnings (EBITDA): -9.6M vs. PGEN (-154.85M). PGEN has more cash in the bank: 80.2M vs. APM (2.01M). APM has less debt than PGEN: APM (3.28M) vs PGEN (5.42M). PGEN has higher revenues than APM: PGEN (4.2M) vs APM (431K).
APMPGENAPM / PGEN
Capitalization6.86M478M1%
EBITDA-9.6M-154.85M6%
Gain YTD-65.71444.643-147%
P/E Ratio3.00N/A-
Revenue431K4.2M10%
Total Cash2.01M80.2M3%
Total Debt3.28M5.42M61%
FUNDAMENTALS RATINGS
APM vs PGEN: Fundamental Ratings
APM
PGEN
OUTLOOK RATING
1..100
8837
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
6541
P/E GROWTH RATING
1..100
27100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APM's Valuation (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for PGEN (70) in the null industry. This means that APM’s stock grew somewhat faster than PGEN’s over the last 12 months.

APM's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PGEN (100) in the null industry. This means that APM’s stock grew similarly to PGEN’s over the last 12 months.

APM's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as PGEN (100) in the null industry. This means that APM’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's Price Growth Rating (41) in the null industry is in the same range as APM (65) in the Pharmaceuticals Major industry. This means that PGEN’s stock grew similarly to APM’s over the last 12 months.

APM's P/E Growth Rating (27) in the Pharmaceuticals Major industry is significantly better than the same rating for PGEN (100) in the null industry. This means that APM’s stock grew significantly faster than PGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APMPGEN
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
APM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BE24.241.68
+7.45%
Bloom Energy Corp
BEN24.880.09
+0.36%
Franklin Resources
HLVX2.11N/A
N/A
HilleVax
VLRS4.81-0.01
-0.21%
CONTROLADORA VUELA COMPAniA DE AVIACIoN SAB DE CV
LCFY5.67-0.33
-5.50%
Locafy Limited

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with ARCT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
+0.62%
ARCT - PGEN
47%
Loosely correlated
+1.17%
CRSP - PGEN
46%
Loosely correlated
+0.97%
XENE - PGEN
46%
Loosely correlated
-0.33%
PRME - PGEN
45%
Loosely correlated
+1.30%
BEAM - PGEN
45%
Loosely correlated
+0.65%
More